• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ALKBH5/MAP3K8 轴调节 PD-L1+巨噬细胞浸润并促进肝细胞癌进展。

ALKBH5/MAP3K8 axis regulates PD-L1+ macrophage infiltration and promotes hepatocellular carcinoma progression.

机构信息

Hepatobiliary Surgery Department, Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, China.

Department of Gastroenterology, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, China.

出版信息

Int J Biol Sci. 2022 Aug 1;18(13):5001-5018. doi: 10.7150/ijbs.70149. eCollection 2022.

DOI:10.7150/ijbs.70149
PMID:35982895
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9379398/
Abstract

Hepatocellular carcinoma is one of the most common malignant tumors.M6A is a novel epigenetic modification that have been emerged as vital regulators for the progression of HCC. However, the regulatory role, clinical significance and the details of the modification, such as the impact on the local tumor environment, remain largely unclear. Our study showed that ALKBH5 was highly expressed in HCC and high ALKBH5 expression predicted a worse prognosis of HCC patients. Prediction of ALKBH5 function by tissue samples and single cell sequencing Gene Set Variation Analysis. Primary CD3 + T lymphocytes and bone marrow-derived macrophages were used to evaluate the effect of ALKBH5 on immune microenvironment. The results indicated that ALKBH5 promote HCC cell proliferation, metastasis and PD-L1+macrophage recruitment. Mechanistically the results showed that ALKBH5 regulates MAP3K8 expression in a m6A dependent manner which mediates the proliferation and metastasis of HCC cells. ALKBH5 also promotes the activation of JNK and ERK pathways through upregulating MAP3K8, thus regulating the expression of IL-8 and promoting macrophage recruitment. Taken together, these data show that ALKBH5 promotes HCC growth, metastasis and macrophage recruitment through ALKBH5/MAP3K8 axis and it may serve as a potential diagnostic marker and target for treatment of HCC patients.

摘要

肝细胞癌是最常见的恶性肿瘤之一。m6A 是一种新出现的表观遗传修饰,已成为 HCC 进展的重要调节剂。然而,其调节作用、临床意义以及修饰的细节(如对局部肿瘤微环境的影响)在很大程度上仍不清楚。我们的研究表明,ALKBH5 在 HCC 中高表达,高 ALKBH5 表达预示着 HCC 患者的预后更差。通过组织样本和单细胞测序基因集变异分析预测 ALKBH5 的功能。原代 CD3+T 淋巴细胞和骨髓来源的巨噬细胞用于评估 ALKBH5 对免疫微环境的影响。结果表明,ALKBH5 促进 HCC 细胞增殖、转移和 PD-L1+巨噬细胞募集。机制研究表明,ALKBH5 以 m6A 依赖的方式调节 MAP3K8 的表达,从而介导 HCC 细胞的增殖和转移。ALKBH5 还通过上调 MAP3K8 促进 JNK 和 ERK 通路的激活,从而调节 IL-8 的表达并促进巨噬细胞募集。综上所述,这些数据表明,ALKBH5 通过 ALKBH5/MAP3K8 轴促进 HCC 的生长、转移和巨噬细胞募集,它可能作为 HCC 患者的潜在诊断标志物和治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41e7/9379398/58cb5f2d2940/ijbsv18p5001g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41e7/9379398/282e9d9270a8/ijbsv18p5001g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41e7/9379398/9b089db821a9/ijbsv18p5001g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41e7/9379398/69427da591b4/ijbsv18p5001g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41e7/9379398/943adc480233/ijbsv18p5001g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41e7/9379398/086a04172e37/ijbsv18p5001g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41e7/9379398/2f337a71d9e2/ijbsv18p5001g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41e7/9379398/f244681095eb/ijbsv18p5001g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41e7/9379398/58cb5f2d2940/ijbsv18p5001g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41e7/9379398/282e9d9270a8/ijbsv18p5001g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41e7/9379398/9b089db821a9/ijbsv18p5001g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41e7/9379398/69427da591b4/ijbsv18p5001g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41e7/9379398/943adc480233/ijbsv18p5001g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41e7/9379398/086a04172e37/ijbsv18p5001g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41e7/9379398/2f337a71d9e2/ijbsv18p5001g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41e7/9379398/f244681095eb/ijbsv18p5001g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41e7/9379398/58cb5f2d2940/ijbsv18p5001g008.jpg

相似文献

1
ALKBH5/MAP3K8 axis regulates PD-L1+ macrophage infiltration and promotes hepatocellular carcinoma progression.ALKBH5/MAP3K8 轴调节 PD-L1+巨噬细胞浸润并促进肝细胞癌进展。
Int J Biol Sci. 2022 Aug 1;18(13):5001-5018. doi: 10.7150/ijbs.70149. eCollection 2022.
2
ALKBH5 promotes non-small cell lung cancer progression and susceptibility to anti-PD-L1 therapy by modulating interactions between tumor and macrophages.ALKBH5 通过调节肿瘤与巨噬细胞之间的相互作用促进非小细胞肺癌的进展和对抗 PD-L1 治疗的敏感性。
J Exp Clin Cancer Res. 2024 Jun 14;43(1):164. doi: 10.1186/s13046-024-03073-0.
3
MA Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma.MA 去甲基化酶 ALKBH5 调控肝内胆管癌中 PD-L1 的表达和肿瘤免疫微环境。
Cancer Res. 2021 Sep 15;81(18):4778-4793. doi: 10.1158/0008-5472.CAN-21-0468. Epub 2021 Jul 23.
4
ALKBH5 suppresses malignancy of hepatocellular carcinoma via mA-guided epigenetic inhibition of LYPD1.ALKBH5 通过 mA 引导的 LYPD1 表观遗传抑制抑制肝癌的恶性程度。
Mol Cancer. 2020 Aug 10;19(1):123. doi: 10.1186/s12943-020-01239-w.
5
Hepatitis B Virus-Mediated m6A Demethylation Increases Hepatocellular Carcinoma Stemness and Immune Escape.乙型肝炎病毒介导的 m6A 去甲基化增加肝癌干细胞特性和免疫逃逸。
Mol Cancer Res. 2024 Jul 2;22(7):642-655. doi: 10.1158/1541-7786.MCR-23-0720.
6
promotes hepatocellular carcinoma cell proliferation, migration and invasion by regulating expression.通过调节表达促进肝癌细胞的增殖、迁移和侵袭。
Biomol Biomed. 2024 Sep 6;24(5):1216-1230. doi: 10.17305/bb.2024.10247.
7
A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis.HBx 与 ALKBH5 之间的正反馈环促进肝细胞癌发生。
BMC Cancer. 2021 Jun 10;21(1):686. doi: 10.1186/s12885-021-08449-5.
8
The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma.m6A 去甲基酶 ALKBH5 通过 IKKε/TBK1/IRF3 通路抑制 RIG-I 表达和干扰素 α 产生,促进头颈部鳞状细胞癌的肿瘤进展。
Mol Cancer. 2022 Apr 9;21(1):97. doi: 10.1186/s12943-022-01572-2.
9
ALKBH5-mediated upregulation of CPT1A promotes macrophage fatty acid metabolism and M2 macrophage polarization, facilitating malignant progression of colorectal cancer.ALKBH5 通过上调 CPT1A 促进巨噬细胞脂肪酸代谢和 M2 型巨噬细胞极化,促进结直肠癌细胞的恶性进展。
Exp Cell Res. 2024 Apr 1;437(1):113994. doi: 10.1016/j.yexcr.2024.113994. Epub 2024 Mar 12.
10
Activation of YAP1 by N6-Methyladenosine-Modified circCPSF6 Drives Malignancy in Hepatocellular Carcinoma.N6-甲基腺苷修饰的 circCPSF6 通过激活 YAP1 促进肝癌恶性进展。
Cancer Res. 2022 Feb 15;82(4):599-614. doi: 10.1158/0008-5472.CAN-21-1628.

引用本文的文献

1
Interactions between ALKBH5 and reader proteins in tumors: functions and molecular mechanisms.肿瘤中ALKBH5与读取蛋白之间的相互作用:功能与分子机制
Front Oncol. 2025 Sep 1;15:1611007. doi: 10.3389/fonc.2025.1611007. eCollection 2025.
2
ALKBH5 deficiency suppresses hepatocarcinogenesis in mice via mA-dependent STAT1 restoration.ALKBH5缺陷通过依赖于N6-甲基腺苷(mA)的信号转导和转录激活因子1(STAT1)恢复来抑制小鼠肝癌发生。
Acta Pharmacol Sin. 2025 Aug 21. doi: 10.1038/s41401-025-01631-6.
3
A four-gene signature identified by integrated transcriptomic analysis for differential diagnosis and prognosis of uterine smooth muscle tumors.

本文引用的文献

1
Single-Cell RNA Sequencing in Multiple Pathologic Types of Renal Cell Carcinoma Revealed Novel Potential Tumor-Specific Markers.多种病理类型肾细胞癌的单细胞RNA测序揭示了新的潜在肿瘤特异性标志物。
Front Oncol. 2021 Oct 14;11:719564. doi: 10.3389/fonc.2021.719564. eCollection 2021.
2
Targeting transcription cycles in cancer.针对癌症中的转录周期。
Nat Rev Cancer. 2022 Jan;22(1):5-24. doi: 10.1038/s41568-021-00411-8. Epub 2021 Oct 21.
3
Defects in Macrophage Reprogramming in Cancer Therapy: The Negative Impact of PD-L1/PD-1.
通过综合转录组分析确定的用于子宫平滑肌肿瘤鉴别诊断和预后的四基因特征。
Front Oncol. 2025 Aug 4;15:1591875. doi: 10.3389/fonc.2025.1591875. eCollection 2025.
4
Mechanistic insights into the role of RNA demethylase ALKBH5 in malignant tumor therapy.RNA去甲基化酶ALKBH5在恶性肿瘤治疗中作用的机制性见解
J Transl Med. 2025 Aug 13;23(1):905. doi: 10.1186/s12967-025-06938-w.
5
Role of m6A RNA methylation regulators in pancreatic cancer: interactions and potential implications.m6A RNA甲基化调节剂在胰腺癌中的作用:相互作用及潜在影响
Cancer Cell Int. 2025 Aug 4;25(1):292. doi: 10.1186/s12935-025-03922-8.
6
Role, mechanism, and application of N6-methyladenosine in hepatobiliary carcinoma.N6-甲基腺苷在肝胆癌中的作用、机制及应用
World J Gastrointest Oncol. 2025 Jun 15;17(6):105140. doi: 10.4251/wjgo.v17.i6.105140.
7
Immune microenvironment in hepatocellular carcinoma: from pathogenesis to immunotherapy.肝细胞癌中的免疫微环境:从发病机制到免疫治疗
Cell Mol Immunol. 2025 Jun 11. doi: 10.1038/s41423-025-01308-4.
8
Role and mechanisms of m6A demethylases in digestive system tumors.m6A去甲基化酶在消化系统肿瘤中的作用及机制
Am J Cancer Res. 2025 Apr 15;15(4):1436-1460. doi: 10.62347/XMAF1290. eCollection 2025.
9
Summary of the mechanism of ferroptosis regulated by m6A modification in cancer progression.m6A修饰调控癌症进展中细胞铁死亡的机制综述。
Front Cell Dev Biol. 2025 Apr 9;13:1507171. doi: 10.3389/fcell.2025.1507171. eCollection 2025.
10
Crosstalk between exosomes and tumor-associated macrophages in hepatocellular carcinoma: implication for cancer progression and therapy.肝细胞癌中外泌体与肿瘤相关巨噬细胞之间的串扰:对癌症进展和治疗的影响
Front Immunol. 2025 Apr 8;16:1512480. doi: 10.3389/fimmu.2025.1512480. eCollection 2025.
癌症治疗中巨噬细胞重编程的缺陷:PD-L1/PD-1 的负面影响。
Front Immunol. 2021 Jun 23;12:690869. doi: 10.3389/fimmu.2021.690869. eCollection 2021.
4
The Emerging Roles of RNA mA Methylation and Demethylation as Critical Regulators of Tumorigenesis, Drug Sensitivity, and Resistance.RNA mA 甲基化和去甲基化作为肿瘤发生、药物敏感性和耐药性的关键调控因子的新兴作用。
Cancer Res. 2021 Jul 1;81(13):3431-3440. doi: 10.1158/0008-5472.CAN-20-4107. Epub 2021 Mar 5.
5
A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis.HBx 与 ALKBH5 之间的正反馈环促进肝细胞癌发生。
BMC Cancer. 2021 Jun 10;21(1):686. doi: 10.1186/s12885-021-08449-5.
6
Gene signature extraction and cell identity recognition at the single-cell level with Cell-ID.利用 Cell-ID 在单细胞水平上进行基因特征提取和细胞身份识别。
Nat Biotechnol. 2021 Sep;39(9):1095-1102. doi: 10.1038/s41587-021-00896-6. Epub 2021 Apr 29.
7
Hepatocellular Carcinoma Immune Landscape and the Potential of Immunotherapies.肝细胞癌的免疫格局与免疫治疗潜力
Front Immunol. 2021 Mar 18;12:655697. doi: 10.3389/fimmu.2021.655697. eCollection 2021.
8
Hepatocellular carcinoma.肝细胞癌。
Nat Rev Dis Primers. 2021 Jan 21;7(1):6. doi: 10.1038/s41572-020-00240-3.
9
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention.非酒精性脂肪性肝病相关肝细胞癌的全球流行病学:趋势、预测、危险因素和预防。
Nat Rev Gastroenterol Hepatol. 2021 Apr;18(4):223-238. doi: 10.1038/s41575-020-00381-6. Epub 2020 Dec 21.
10
The epitranscriptome beyond mA.非 mA 修饰的转录组学。
Nat Rev Genet. 2021 Feb;22(2):119-131. doi: 10.1038/s41576-020-00295-8. Epub 2020 Nov 13.